ArticleOncotarget2017

Efficacy and safety of first-line pemetrexed plus carboplatin followed by single-agent pemetrexed maintenance in elderly Chinese patients with non-squamous non-small-cell lung cancer.

Xinmin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.